Growth PotentialWith the anticipated commercial availability of the ROSA Shoulder System in the US, ZBH is poised to tap into the substantial U.S. Shoulder market, offering a promising avenue for revenue growth and market share expansion.
Innovation And Market LeadershipZBH's groundbreaking ROSA Shoulder System has secured FDA 510(k) clearance, heralding a new era in robotic-assisted shoulder replacement surgery and positioning ZBH as an industry pioneer.
Strategic AcquisitionsZBH's strategic move to acquire VIMS, a company specializing in advanced visualization systems for minimally invasive procedures, signals a robust commitment to innovation and enhancing its competitive edge in surgical technologies.